Dexamethasone Treatment Not Linked to Improved Survival in COVID …
Dec 12, 2024 · Dexamethasone treatment was not associated with improved survival nor clinical outcomes among patients with COVID-19 and diabetes.
Tuberculosis Screening Gaps Possible in the Evolving Immunotherapy ...
Jan 26, 2026 · Prescribing information and clinical guidelines showed gaps in TB screening protocols for many recently approved targeted immunotherapies.
FDA Drug Approval Decisions Expected in March 2026
Feb 12, 2026 · The FDA is expected to decide on the supplemental NDA for deucravacitinib for the treatment of adults with active psoriatic arthritis (PsA). The application is supported by data from the …
Underlying disorders PVT BCS NCPH Table I. Prevalence of acquired and inherited risk factors for BCS, PVT, and cirrhotic portal hypertension
Treatment of Incident PAH Deviates From Current Guideline …
Jan 27, 2026 · Patients newly diagnosed with PAH are often undertreated relative to treatment recommendations outlined in current guidelines.
Target: BP™ Initiative for Improving Hypertension Care
Dec 20, 2024 · The Target Blood Pressure (BP) initiative is a nationwide movement to improve blood pressure control for almost half of American adults living with hypertension. Over a thousand health …
Association of Black Cardiologists Launches Hypertension Management ...
Feb 12, 2024 · The Association of Black Cardiologists (ABC) is offering a Hypertension Control Program (HCP) certification for clinicians committed to preventing hypertension and improving hypertension …
Decrease in Mortality Rate for Atherosclerotic Cardiovascular Disease ...
May 15, 2024 · The decreasing trend in mortality has slowed in the past 2 decades among US adult patients with atherosclerotic cardiovascular disease.
Sarah A. Steimel, PhD, Author at The Cardiology Advisor
Jun 14, 2024 · Sarah A. Steimel joined Haymarket as a Medical Editor for Psychiatry Advisor after completing her PhD in neuroscience at Dartmouth College in 2023. She writes and edits medical …
JAK Inhibitors Linked to Increased Reporting of Adverse Cardiovascular ...
Jul 26, 2024 · Results of a global postmarketing study confirmed the association between JAK inhibitors and adverse cardiovascular events among patients with RA.